Unihealth Hospitals Ltd Q2 FY26 – The African Dream Run Meets Indian Hustle, 195% Profit Jump with 48% Margins!
1. At a Glance
Let’s start with the kind of headline that would make any doctor proud: Unihealth Hospitals Ltd just reported a 195% YoY jump in profits, a sizzling 48% operating margin, and a 120% stock return in the last three months. Not bad for a company that began as a medical tour operator and now manages hospitals across Uganda, Nigeria, and Tanzania, while building a healthcare empire back home in India.
At a market cap of ₹549 crore, Unihealth is what happens when a bunch of desi doctors and consultants decided that Africa deserves better hospitals — and that they deserve better valuations. The current price sits at ₹354, up from ₹120 just six months ago, leaving early investors feeling like they found the vaccine for bad returns. The stock P/E stands at 22.8, quite a steal compared to the 56x median P/E of Indian hospital peers like Apollo and Fortis.
The latest H1FY26 results read like a health check-up report of a marathon runner: Revenue up 55% to ₹70 crore, EBITDA ₹35 crore, and net profit ₹28.6 crore. With the new Navi Mumbai hospital operational and Nashik 200-bed facility launching in early 2026, Unihealth seems to be running an Indo-African relay race — and so far, they’re winning every lap.
2. Introduction
Every once in a while, the Indian SME space produces a story so cinematic that even Netflix would call it “too optimistic.” Unihealth Hospitals Ltd is one of those rare cross-border healthcare adventures — a company that somehow manages to run hospitals in Africa, ship pharmaceuticals from India, and still find time to plan new hospitals faster than you can say “ICU.”
Founded in 2010 in Mumbai, Unihealth began as a medical tour operator — basically arranging treatments in India for foreign patients who preferred a flight to Mumbai over a long wait in Kampala. Fast forward to 2025, and they’re not just arranging treatments; they’re running the hospitals themselves under the “UMC” brand — short for Unihealth Medical Centre.
They now operate in Uganda, Nigeria, and Tanzania, with over 200 hospital beds and more than 1.3 lakh patients treated annually. And just when you think this was an Africa-only play, they’ve decided to go full desi again with plans to build five new hospitals across Western India.
You know how Bollywood has “Desi Boyz”? Well, this is “Desi Docs,” featuring board-certified MBAs, African partnerships, and a storyline that’s part healthcare revolution, part startup hustle.
3. Business Model – WTF Do They Even Do?
Unihealth’s business model is like a thali — everything’s on the plate, and somehow, it works beautifully together.
1. Hospitals & Medical Centres (82% of FY25 revenue): This is the main course. Unihealth runs UMC Victoria Hospital (120 beds, Uganda), UMC Zhahir Hospital (80 beds, Nigeria), and a dialysis facility in Tanzania. It’s not Apollo yet, but give it time — margins already rival them at 43% OPM.
2. Pharma Exports (8.5%): Through its subsidiary Unihealth Pharmaceuticals Pvt Ltd, it distributes medical consumables and pharma products across Africa, including brands like Reliance Lifesciences and Levram Lifesciences.
3. Healthcare Consultancy (4.5%): The company advises other hospitals on project design, architecture, and setup — like a doctor who also sells the hospital blueprint.
4. Medical Value Travel: Still true to its roots, Unihealth facilitates international patient travel to India through tie-ups with Myanmar Airways and Ethiopian Airlines.
5. Other Income (5%): Because why not? A healthy mix of interest income, service fees, and rent.
So yes — they treat patients, build hospitals, supply consumables, and run consulting gigs. Think of it as the Infosys of Healthcare, except instead of coding bugs, they’re fixing bones.
4. Financials Overview (Quarterly Data – ₹ in Crores)
Metric
Latest Qtr (Sep 25)
Same Qtr Last Year (Sep 24)
Prev Qtr (Mar 25)
YoY %
QoQ %
Revenue
66.7
43.3
56.0
54.1%
19.1%
EBITDA
32.0
15.0
21.0
113%
52.4%
PAT
15.1
5.1
8.0
195%
88.8%
EPS (₹)
9.75
3.30
5.10
195%
91.2%
Reporting Type: Quarterly (H1FY26 = Sep’25).
Annualised EPS = ₹9.75 × 4 = ₹39.0 At CMP ₹354, that’s a P/E of ~9.1x annualised earnings. Even with a hospital gown on, that valuation looks healthy.
Commentary: Unihealth is literally minting profits from African operations while the rest of the sector is still fighting for OPD footfalls. EBITDA margin expanded to 48%, meaning every rupee of cost is working
